Modificare „ADAPTIVE BIOTECHNOLOGIES CORP”

Pagina dedicata companiei ADAPTIVE BIOTECHNOLOGIES CORP listata cu simbolul US.ADPT

==Descriere companie==
Adaptive Biotechnologies Corporation (https://www.adaptivebiotech.com/) is a commercial-stage company. The Company is focused on using the biology of the adaptive immune system to develop the diagnosis and treatment of disease. Its immune medicine platform combines a suite of chemistry, biology and machine learning to generate clinical immunomics data to decode the adaptive immune system. Its commercial research products include immunoSEQ and immunoSEQ T-MAP. immunoSEQ utilizes bias-controlled polymerase chain reaction (PCR) to sequence immune receptors from deoxyribonucleic (DNA). Its clonoSEQ diagnostic test detects and monitors the number of cancer cells that are present in a patient’s body during and after treatment, known as minimal residual disease (MRD). It uses its T cell receptor (TCR)-Antigen Map to develop research solutions and diagnostic products, such as immunoSEQ T-MAP and T-Detect. It also focuses on developing immune-mediated therapies in oncology and other disease areas.

==Grafic actiuni companie==
<iframe key="tradeville" path="graficSimbol/US.ADPT" />

==Ultimele stiri despre ADAPTIVE BIOTECHNOLOGIES CORP (US.ADPT)==
<dynamicpagelist>
category=US.ADPT
count=10
order=descending
addfirstcategorydate=false
</dynamicpagelist>

[[Categorie:US.ADPT]][[Categorie:Stiri despre companii]]